Hikma Pharmaceuticals

Hikma is a multinational pharmaceutical group dedicated to improving the health and wellbeing of people in the markets it serves through the development, manufacturing and marketing of a broad range of solid, liquid and injectable generic and in-licensed pharmaceutical products.
Hikma is a leading generic pharmaceutical company with a significant presence in the Middle East and North Africa (MENA) region, the United States and Europe. It was first listed on the London Stock Exchange in 2005 is now a constituent of the FTSE 100 Index.

Type
Public
HQ
London, GB
Founded
1978
Size (employees)
7,189 (est)
Website
hikma.com
Hikma Pharmaceuticals was founded in 1978 and is headquartered in London, GB

Hikma Pharmaceuticals Office Locations

Hikma Pharmaceuticals has offices in London, Beirut, Cairo, Lebanon and in 2 other locations
London, GB (HQ)
13 Hanover Square

Hikma Pharmaceuticals Data and Metrics

Hikma Pharmaceuticals Financial Metrics

Hikma Pharmaceuticals's revenue was reported to be £996.7 m in FY, 2015 which is a 3% decrease from the previous period.
Numbers are in £, GBP

Revenue (FY, 2015)

996.7 m

Revenue growth (FY, 2014 - FY, 2015), %

(3%)

Gross profit (FY, 2015)

566.2 m

Gross profit margin (FY, 2015), %

57%

Net income (FY, 2015)

175.8 m

Market capitalization (26-May-2017)

4.1 b

Closing share price (26-May-2017)

16.7

Cash (31-Dec-2015)

410.4 m
Hikma Pharmaceuticals's current market capitalization is £4.1 b.
Numbers are in £, GBPFY, 2013FY, 2014FY, 2015

Revenue

897.6 m1 b996.7 m

Revenue growth, %

15%(3%)

Cost of goods sold

395.2 m441.6 m430.5 m

Gross profit

502.4 m589 m566.2 m

Gross profit Margin, %

56%57%57%

Operating expense total

270.9 m310.8 m302.5 m

Pre tax profit

196 m250.6 m220.1 m

Net Income

142 m195.2 m175.8 m
Numbers are in £, GBPFY, 2013FY, 2014FY, 2015

Cash

115.1 m199.3 m410.4 m

Accounts Receivable

253.2 m265.8 m299 m

Current Assets

589.9 m701.1 m941.3 m

PP&E

384.7 m440.2 m436 m

Goodwill

293.9 m416.7 m420.1 m

Total Assets

1.3 b1.6 b1.8 b

Accounts Payable

78.9 m89.3 m96.2 m

Current Liabilities

385.3 m582.1 m409.7 m

Retained Earnings

113.8 m154.3 m130.1 m

Total Equity

668.8 m828.5 m925.4 m

Financial Leverage

1.9 x1.9 x1.9 x
Numbers are in £, GBPFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

221.6 m294.2 m253.3 m

Cash From Financing Activities

(150.6 m)20.8 m53.3 m

Income Taxes Paid

(53.9 m)(55.4 m)(44.3 m)
Numbers are in £, GBPY, 2015

Revenue/Employee

138.6 k

Financial Leverage

1.9 x

Hikma Pharmaceuticals Market Value History

Hikma Pharmaceuticals Online and Social Media Presence

Hikma Pharmaceuticals News and Updates

Hikma Pharmaceuticals Company Life and Culture

You may also be interested in